Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis (Q34545376)

2 August 2017

1 reference

title

Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis (English)

1 reference

2 August 2017

1 reference

4

Jacques Magdalou

1 reference

2 August 2017

Nicole Fabien

1

1 reference

PubMed ID

14871643

2 August 2017

Agnès Desbos

series ordinal

2

1 reference

PubMed ID

14871643

2 August 2017

Jacques Bienvenu

series ordinal

3

1 reference

2 August 2017

1 January 2004

1 reference

2 August 2017

1 reference

2 August 2017

3

1 reference

2 August 2017

1

1 reference

2 August 2017

1-9

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

1 reference

7 January 2021

Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Autoimmune hepatitis in childhood: a 20-year experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Liver/kidney microsome antibody type 1 and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Structure and function of uridine diphosphate glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

The glucuronosyltransferases: what progress can pharmacologists expect from molecular biology and cellular enzymology?

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Glycation of human serum albumin by acylglucuronides of nonsteroidal anti-inflammatory drugs of the series of phenylpropionates

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyodeoxycholic acid in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Immunocharacterization of UDP-glucuronyltransferase isoenzymes in human liver, intestine and kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Human and rat liver UDP-glucuronosyltransferases are targets of ketoprofen acylglucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900051-X

7 January 2021

10.1016/S1568-9972(03)00051-X

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

14871643